Elevance Health, Inc. (NYSE:ELV – Free Report) – Equities research analysts at Cantor Fitzgerald cut their FY2025 earnings per share estimates for shares of Elevance Health in a report released on Friday, January 24th. Cantor Fitzgerald analyst S. James now anticipates that the company will earn $34.57 per share for the year, down from their prior forecast of $34.65. Cantor Fitzgerald has a “Overweight” rating and a $485.00 price target on the stock. The consensus estimate for Elevance Health’s current full-year earnings is $32.95 per share.
Elevance Health (NYSE:ELV – Get Free Report) last released its quarterly earnings data on Thursday, January 23rd. The company reported $3.84 earnings per share for the quarter, topping analysts’ consensus estimates of $3.80 by $0.04. Elevance Health had a net margin of 3.68% and a return on equity of 19.56%.
Check Out Our Latest Research Report on ELV
Elevance Health Stock Performance
ELV opened at $405.67 on Monday. The company has a current ratio of 1.50, a quick ratio of 1.50 and a debt-to-equity ratio of 0.56. The business’s 50 day moving average is $386.42 and its 200-day moving average is $460.49. The stock has a market cap of $94.08 billion, a PE ratio of 14.79, a price-to-earnings-growth ratio of 1.11 and a beta of 0.84. Elevance Health has a twelve month low of $362.21 and a twelve month high of $567.26.
Institutional Investors Weigh In On Elevance Health
A number of large investors have recently made changes to their positions in the company. Raelipskie Partnership purchased a new position in Elevance Health during the 3rd quarter worth approximately $26,000. PSI Advisors LLC acquired a new stake in shares of Elevance Health in the third quarter worth $27,000. Eastern Bank purchased a new position in shares of Elevance Health during the third quarter valued at $31,000. Crews Bank & Trust acquired a new position in Elevance Health during the fourth quarter valued at $34,000. Finally, Dunhill Financial LLC lifted its stake in Elevance Health by 57.8% in the 3rd quarter. Dunhill Financial LLC now owns 71 shares of the company’s stock worth $37,000 after acquiring an additional 26 shares in the last quarter. Institutional investors and hedge funds own 89.24% of the company’s stock.
Elevance Health Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 25th. Shareholders of record on Monday, March 10th will be issued a dividend of $1.71 per share. This represents a $6.84 annualized dividend and a yield of 1.69%. The ex-dividend date of this dividend is Monday, March 10th. This is an increase from Elevance Health’s previous quarterly dividend of $1.63. Elevance Health’s payout ratio is presently 23.77%.
About Elevance Health
Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.
Featured Articles
- Five stocks we like better than Elevance Health
- Which Wall Street Analysts are the Most Accurate?
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- The Basics of Support and Resistance
- What Does the Future Hold for Eli Lilly?
- The How And Why of Investing in Oil Stocks
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.